project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZY; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.7; age at index: 71; days to birth: -26197; days to death: 824; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1935; year of death: 2008; age at diagnosis: 26197; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1848; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: 483d87a4-7427-4be0-83c2-32807c2d3a59; sample submitter id: TCGA-FS-A1ZY-06A; portion id: c7c641df-cd15-4da4-ae3d-c4b6d2dd601e; portion submitter id: TCGA-FS-A1ZY-06A-11; slide id: 7a1b817b-d60d-45fc-926b-5d51b028448d; slide submitter id: TCGA-FS-A1ZY-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; section location: TOP;